The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States

被引:79
|
作者
Brown, Joshua D. [1 ]
Harnett, James [2 ]
Chambers, Richard [3 ]
Sato, Reiko [4 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA
[2] Pfizer Inc, Real World Data & Analyt, Global Hlth & Value, New York, NY USA
[3] Pfizer Inc, Stat Res Data Ctr, Global Prod Dev, Collegeville, PA USA
[4] Pfizer Inc, Global Hlth & Value, Outcomes & Evidence, Collegeville, PA USA
来源
BMC GERIATRICS | 2018年 / 18卷
关键词
Community-acquired pneumonia; Burden of illness; Geriatrics; Vaccinations; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; IMMUNIZATION PRACTICES ACIP; CONJUGATE VACCINE; ADVISORY-COMMITTEE; COST-EFFECTIVENESS; MEDICARE BENEFICIARIES; INFLUENZA VACCINATION; ADMINISTRATIVE DATA; POPULATION;
D O I
10.1186/s12877-018-0787-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: The risk of community-acquired pneumonia (CAP) increases with age and significantly impacts morbidity and mortality in the elderly population. The burden of illness and cost of preventing CAP has not been compared to other serious diseases. Methods: This retrospective analysis used claims data from 2014 to 2015 and compared hospitalizations for CAP, myocardial infarction (MI), stroke, and osteoporotic fractures (OF) in adults aged >= 65 years enrolled in a Medicare Advantage insurance plan. Individuals who had not already been hospitalized for one of these conditions and did not have evidence of long-term care were included in the study. Hospitalizations for each condition were described by length of stay, readmissions, mortality, and total costs. Preventive measures included vaccinations for CAP and medications for MI, stroke, and OF. Results: A total of 1,949,352 individuals were included in the cohort. In 2015, the rate of CAP-related hospitalizations was the highest at 846.7 per 100,000 person-years compared to 405 for MI, 278.9 for stroke, and 343.9 for OF. Vaccination costs for CAP were $40.2 million including $14.1 million for pneumococcal and $26.1 million for influenza vaccines. The cost of preventive medications for MI and stroke reached over $661 million and OF totaled $169 million. Conclusions: Although CAP has a higher burden of hospitalization and total costs than MI, stroke, and OF in the elderly population, prevention efforts were disproportionately smaller for CAP. Prioritization of CAP prevention is needed to substantially reduce the burden of CAP.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The burden of community-acquired pneumonia in Spain
    Monge, V
    San-Martín, M
    González, A
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2001, 11 (04): : 362 - 364
  • [22] Epidemiology of community-acquired pneumonia in older adults: A population-based study
    Vila-Corcoles, Angel
    Ochoa-Gondar, Olga
    Rodriguez-Blanco, Teresa
    Raga-Luria, Xavier
    Gomez-Bertomeu, Frederic
    RESPIRATORY MEDICINE, 2009, 103 (02) : 309 - 316
  • [23] Community-Acquired Pneumonia in Older and Younger Adults With Diabetes Mellitus
    Bader, Mazen
    Yi, Yanqing
    Abouchehade, Kassem
    Bishop, Lisa
    Hawboldt, John
    CHEST, 2015, 148 (04)
  • [24] Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort
    Akihiro Ito
    Tadashi Ishida
    Hironobu Tokumasu
    Yasuyoshi Washio
    Akio Yamazaki
    Yuhei Ito
    Hiromasa Tachibana
    BMC Pulmonary Medicine, 17
  • [25] A model for predicting bacteremia in patients with community-acquired pneumococcal pneumonia: a retrospective observational study
    Washio, Yasuyoshi
    Ito, Akihiro
    Kumagai, Shogo
    Ishida, Tadashi
    Yamazaki, Akio
    BMC PULMONARY MEDICINE, 2018, 18
  • [26] Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort
    Ito, Akihiro
    Ishida, Tadashi
    Tokumasu, Hironobu
    Washio, Yasuyoshi
    Yamazaki, Akio
    Ito, Yuhei
    Tachibana, Hiromasa
    BMC PULMONARY MEDICINE, 2017, 17
  • [27] A retrospective observational study of biomarker levels and severity assessment in pediatric community-acquired pneumonia
    Bashir, Anam
    Khan, Raheel
    Thompson, Stephanie
    Caceres, Manuel
    MEDICINE, 2022, 101 (32) : E30010
  • [28] A model for predicting bacteremia in patients with community-acquired pneumococcal pneumonia: a retrospective observational study
    Yasuyoshi Washio
    Akihiro Ito
    Shogo Kumagai
    Tadashi Ishida
    Akio Yamazaki
    BMC Pulmonary Medicine, 18
  • [29] Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults
    Saatchi, Ariana
    Reid, Jennifer N.
    Shariff, Salimah Z.
    Povitz, Marcus
    Silverman, Michael
    Patrick, David M.
    Morris, Andrew M.
    Mccormack, James
    Haverkate, Manon R.
    Marra, Fawziah
    PLOS ONE, 2023, 18 (10):
  • [30] BURDEN OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS OVER 18 YEARS OF AGE
    Cuhadaroglu, C.
    Alici, D. E.
    Hacibedel, B.
    Saribas, G.
    Kosar, F.
    VALUE IN HEALTH, 2015, 18 (07) : A497 - A498